Key result
Living in a low socioeconomic status neighborhood was associated with worse overall survival among adolescents and young adults with localized synovial sarcoma.
Why the study?
Synovial sarcoma requires multidisciplinary multimodal care, but the impact of sociodemographic and clinical factors on treatment patterns and survival in localized disease remains unclear.
What sociodemographic and clinical factors influence treatment patterns and survival in patients with localized synovial sarcoma?
Cohort (n=618)
Yes
What sociodemographic and clinical factors influence treatment patterns and survival in patients with localized synovial sarcoma?
Answers are grounded in this paper and cite their sources.
In patients with localized synovial sarcoma, sociodemographic factors such as socioeconomic status and insurance type significantly influence treatment patterns and survival outcomes, highlighting disparities in care.
Purpose:Synovial sarcoma (SS) is a rare, high-grade soft tissue tumor that requires multidisciplinary and multimodal care with surgery, radiotherapy, and chemotherapy. We examined the impact of sociodemographic and clinical factors on treatment patterns and survival in localized SS patients. Methods:Adolescents and young adults (AYAs, 15–39 years) and older adults (“adults,” ≥40 years) diagnosed with localized SS from 2000 to 2018 were identified in the California Cancer Registry. Multivariable logistic regression identified clinical and sociodemographic factors associated with receipt of chemotherapy and/or radiotherapy. Cox proportional hazards regression identified factors associated with overall survival (OS). Results are reported as odds ratios (ORs) and hazard ratios (HRs), respectively, with 95% confidence intervals (CIs). Results:More AYAs (n = 346) than adults (n = 272) received chemotherapy (47.7% vs. 36.4%) and radiotherapy (62.1% vs. 58.1%). Age at diagnosis, tumor size, treatment at National Cancer Institute-Children's Oncology Group (NCI-COG)-designated facilities, insurance status, and neighborhood socioeconomic status (SES) influenced treatment patterns. Among AYAs, treatment at NCI-COG-designated facilities was associated with receiving chemotherapy (OR 2.74, CI 1.48–5.07) and low SES was associated with worse OS (HR 2.28, 1.09–4.77). In adults, high SES was associated with receiving chemoradiotherapy (OR 3.20, CI 1.40–7.31), whereas public insurance was associated with decreased odds of chemoradiotherapy (OR 0.44, CI 0.20–0.95). With regard to treatment, absence of radiotherapy (HR 1.94, CI 1.18–3.20) was associated with worse OS in adults. Conclusion:In localized SS, both clinical and sociodemographic factors influenced treatment patterns. Further research should investigate how SES-related factors produce treatment disparities and identify interventions to improve treatment equity and outcomes.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2023) conducted a cohort in Localized Synovial Sarcoma (n=618). Low neighborhood socioeconomic status vs. High neighborhood socioeconomic status was evaluated on Overall survival in adolescents and young adults (AYAs) (HR 2.28, 95% CI 1.09-4.77, p=0.028). Living in a low socioeconomic status neighborhood was associated with worse overall survival among adolescents and young adults with localized synovial sarcoma.
Synapse has enriched 10 related papers. Consider them for comparative context: